Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer?
Aoba OkeyaAkihiko ShimomuraDai KitagawaChikako ShimizuPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)